INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.70B / 21S · 11 late91 trades$26.34M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 33S33 trades$5.33M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

19,519 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
55
FH
Frank Edward H.Director
RKLBRocket Lab Corp
Open-market sale
SELL$193K
2,500 sh
Dec 23, 2025Dec 30, 2025
Page 407 of 488
← PrevNext →
traded Dec 23, 2025
+7d
SEC Form 4

Evidence

49
MC
Maroney Dawn ChristinePresident
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$4.99M
266.6K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

49
SL
Scavo Robert L.Chief Information Officer
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$1.23M
65.7K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

42
JJ
Joyce Christopher JChief Legal and Admin. Officer
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$286K
15.3K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

42
MC
Maroney Dawn ChristinePresident
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$300K
15.5K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

42
BD
Brazeal Mark DavidChief Legal & Corp Affairs Ofc
AVGOBroadcom Inc.
Open-market sale
SELL$9.13M
25.9K sh
Dec 26, 2025Dec 30, 2025
traded Dec 26, 2025
+4dSEC Form 4

Evidence

42
KE
Kao John EDirector, Chief Executive Officer
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$644K
33.2K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

40
GA
Georgiadis AnthonyDirector, PRESIDENT
GTIIGTBIFGreen Thumb Industries Inc.
Open-market sale
SELL$2.00M
2,500 sh
Dec 28, 2025Dec 30, 2025
traded Dec 28, 2025
+2dSEC Form 4

Evidence

39
KH
Kim HyongChief Medical Officer
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$224K
12.0K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

39
SL
Scavo Robert L.Chief Information Officer
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$74K
3,813 sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

36
JJ
Joyce Christopher JChief Legal and Admin. Officer
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$17K
888 sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

36
KB
Kovler BenjaminDirector, CHAIRMAN & CEO, 10% Owner
GTIIGTBIFGreen Thumb Industries Inc.
Open-market sale
SELL$2.00M
2,500 sh
Dec 28, 2025Dec 30, 2025
traded Dec 28, 2025
+2dSEC Form 4

Evidence

36
KH
Kim HyongChief Medical Officer
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$13K
696 sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

35
PM
Patel Ketan MPresident, Personal Systems
HPQHP INC
Open-market sale
SELL$773K
33.3K sh
Dec 26, 2025Dec 30, 2025
traded Dec 26, 2025
+4dSEC Form 4

Evidence

34
KB
Kravitz BretGENERAL COUNSEL AND SECRETARY
GTIIGTBIFGreen Thumb Industries Inc.
Open-market sale
SELL$58K
7,337 sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

31
OL
Ostrom Ryan LeeEVP, Chief Cust&Digtl Officer
JACKJACK IN THE BOX INC
Open-market sale
SELL$11K
581 sh
Dec 30, 2025Dec 30, 2025
traded Dec 30, 2025
+0dSEC Form 4

Evidence

31
SL
Super Sarah LEVP, Chief Legal&Admin Officer
JACKJACK IN THE BOX INC
Open-market sale
SELL$8,446
434 sh
Dec 30, 2025Dec 30, 2025
traded Dec 30, 2025
+0dSEC Form 4

Evidence

31
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$7.35M
14.6K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

31
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$3.96M
7,875 sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

30
KB
Kravitz BretGENERAL COUNSEL AND SECRETARY
GTIIGTBIFGreen Thumb Industries Inc.
Open-market sale
SELL$106K
12.7K sh
Dec 30, 2025Dec 30, 2025
traded Dec 30, 2025
+0dSEC Form 4

Evidence

28
TJ
Tsay Caroline JDirector
MORNMorningstar, Inc.
Open-market sale
SELL$131K
600 sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

27
SE
Susi Roger E.Director, CEO, PRESIDENT, CHAIRMAN, 10% Owner
IRMDIRADIMED CORP
Open-market sale
SELL$478K
4,899 sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

27
Cook Scott DDirector
INTUINTUIT INC.
Open-market sale · 10b5-1 plan
SELL$12.99M
19.3K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

27
CD
Cook Richard DSVP, CHIEF TECHNOLOGY OFFICER
JACKJACK IN THE BOX INC
Open-market sale
SELL$5,682
292 sh
Dec 30, 2025Dec 30, 2025
traded Dec 30, 2025
+0dSEC Form 4

Evidence

27
SJ
Swallow JohnDirector, President & CEO
IDRIdaho Strategic Resources, Inc.
Open-market sale
SELL$834K
20.0K sh
Dec 30, 2025Dec 30, 2025
traded Dec 30, 2025
+0dSEC Form 4

Evidence

27
Cook Scott DDirector
INTUINTUIT INC.
Open-market sale · 10b5-1 plan
SELL$11.87M
17.7K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

27
Cook Scott DDirector
INTUINTUIT INC.
Open-market sale · 10b5-1 plan
SELL$10.89M
16.2K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

24
Cook Scott DDirector
INTUINTUIT INC.
Open-market sale · 10b5-1 plan
SELL$2.90M
4,290 sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

24
Cook Scott DDirector
INTUINTUIT INC.
Open-market sale · 10b5-1 plan
SELL$1.45M
2,154 sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

24
Cook Scott DDirector
INTUINTUIT INC.
Open-market sale · 10b5-1 plan
SELL$8.09M
12.0K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

24
Cook Scott DDirector
INTUINTUIT INC.
Open-market sale · 10b5-1 plan
SELL$1.66M
2,446 sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

23
Marshall William SpencerDirector, Co-Founder and CEO
PLPlanet Labs PBC
Open-market sale · 10b5-1 plan
SELL$3.87M
200.0K sh
Dec 26, 2025Dec 30, 2025
traded Dec 26, 2025
+4dSEC Form 4

Evidence

23
SH
Schingler Robert HDirector, Co-Founder Chief Strategy Off.
PLPlanet Labs PBC
Open-market sale · 10b5-1 plan
SELL$1.43M
73.8K sh
Dec 26, 2025Dec 30, 2025
traded Dec 26, 2025
+4dSEC Form 4

Evidence

22
AR
Azamian Bobak R.Director, President/CEO and Board Chair
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$449K
5,443 sh
Dec 24, 2025Dec 30, 2025
traded Dec 24, 2025
+6dSEC Form 4

Evidence

21
Cook Scott DDirector
INTUINTUIT INC.
Open-market sale · 10b5-1 plan
SELL$651K
960 sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

21
SE
Susi Roger E.Director, CEO, PRESIDENT, CHAIRMAN, 10% Owner
IRMDIRADIMED CORP
Open-market sale
SELL$9,929
101 sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

20
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$43K
6,831 sh
Dec 23, 2025Dec 30, 2025
traded Dec 23, 2025
+7dSEC Form 4

Evidence

20
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$9,342
1,490 sh
Dec 24, 2025Dec 30, 2025
traded Dec 24, 2025
+6dSEC Form 4

Evidence

18
TR
Taylor Ben RChief Financial Officer
RXRXRECURSION PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$89K
21.4K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

17
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$583K
38.8K sh
Dec 24, 2025Dec 30, 2025
traded Dec 24, 2025
+6dSEC Form 4

Evidence